Vertex Pharmaceuticals (VRTX) has a market capitalization of $115.9B, based on 256.39M shares at a price of $452.13 (down 0.5% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
January 2026 | $452.13 | 825,333 | 256,390,666 | $115,921,911,818.58 |
December 2025 | $453.36 | 28,764,846 | 257,600,000 | $116,785,536,000.00 |
November 2025 | $433.61 | 27,785,394 | 257,600,000 | $111,697,936,000.00 |
October 2025 | $425.57 | 30,425,800 | 257,600,000 | $109,626,832,000.00 |
September 2025 | $391.64 | 35,386,600 | 257,600,000 | $100,886,464,000.00 |
August 2025 | $391.02 | 53,016,200 | 257,600,000 | $100,726,752,000.00 |
July 2025 | $456.87 | 23,714,800 | 257,600,000 | $117,689,712,000.00 |
June 2025 | $445.20 | 26,309,900 | 258,900,000 | $115,262,280,000.00 |
May 2025 | $442.05 | 45,483,900 | 258,900,000 | $114,446,745,000.00 |
April 2025 | $509.50 | 34,969,805 | 258,900,000 | $131,909,550,000.00 |
March 2025 | $484.82 | 29,025,912 | 259,500,000 | $125,810,790,000.00 |
February 2025 | $479.79 | 27,458,785 | 259,500,000 | $124,505,505,000.00 |
January 2025 | $461.68 | 31,740,299 | 259,500,000 | $119,805,960,000.00 |
December 2024 | $402.70 | 38,618,186 | 260,500,000 | $104,903,350,000.00 |
November 2024 | $468.13 | 28,841,960 | 260,500,000 | $121,947,865,000.00 |
October 2024 | $475.98 | 23,166,537 | 260,500,000 | $123,992,790,000.00 |
September 2024 | $465.08 | 20,106,588 | 261,000,000 | $121,385,880,000.00 |
August 2024 | $495.89 | 26,957,969 | 261,000,000 | $129,427,290,000.00 |
July 2024 | $495.72 | 21,577,912 | 261,000,000 | $129,382,920,000.00 |
June 2024 | $468.72 | 25,827,518 | 258,100,000 | $120,976,632,000.00 |
May 2024 | $455.34 | 26,600,170 | 258,100,000 | $117,523,254,000.00 |
April 2024 | $392.81 | 21,206,035 | 258,100,000 | $101,384,261,000.00 |
March 2024 | $418.01 | 20,145,646 | 261,100,000 | $109,142,411,000.00 |
February 2024 | $420.74 | 29,142,917 | 261,100,000 | $109,855,214,000.00 |
January 2024 | $433.38 | 31,309,581 | 261,100,000 | $113,155,518,000.00 |
